Related Experiment Videos
Occurrence of HLA types in H. influenzae type B disease
Insights
Genetic markers influence susceptibility to invasive Haemophilus influenzae type b disease in children. Specific HLA types were associated with invasive versus noninvasive infections, suggesting a genetic basis for disease severity.
Area of Science:
- Pediatric Infectious Diseases
- Immunogenetics
- Microbiology
Background:
- Haemophilus influenzae type b (Hib) causes significant pediatric illness.
- Distinguishing invasive from noninvasive Hib disease is crucial for patient management.
- Genetic factors may play a role in disease presentation.
Purpose of the Study:
- To investigate potential differences in genetic markers between children with invasive and noninvasive Hib disease.
- To determine if specific human leukocyte antigen (HLA) types are associated with invasive Hib disease.
Main Methods:
- Study included 50 Caucasoid children under 7 years with Hib disease.
- Patients were divided into invasive (Group A) and noninvasive (Group B) disease groups based on culture results.
- Genetic markers (HLA typing) were compared between the two groups.
Main Results:
- Significant differences in genetic markers were observed between Group A and Group B.
- HLA-B12 was more prevalent in the invasive group (52% vs. 16%).
- HLA-Bw40 was more prevalent in the noninvasive group (24% vs. 0%).
Conclusions:
- Genetic predisposition, specifically certain HLA types, may influence susceptibility to invasive Hib disease.
- Findings suggest a genetically determined resistance or susceptibility to developing invasive Hib infections.
- Further research into the immunogenetics of Hib disease is warranted.
Abstract:
We have studied 50 Caucasoid children under 7 years of age with Haemophilus influenzae b disease. Half of the patients (Group A) had invasive disease shown by positive blood and/or spinal fluid culture. The other half (Group B) had noninvasive disease characterized by fever, nasopharyngitis, negative blood culture, and positive throat culture. Age, number of other siblings under 12 years old in the family, immune response, antibody production and genetic markers were compared in the two groups. Significant difference between the two groups was only seen in their genetic markers. HLA-B12 was present in 52% of Group A patients as opposed to 16% in Group B patients (P less than .01). HLA-Bw40 was present in 24% of group B patients and absent in all Group A patients (P less than .01). These findings would suggest that susceptibility and resistance towards developing invasive type b disease may be genetically determined.